Select Publications
Books
2014, Management of Mental Disorders, Andrews G; Dean K; Genderson M; Hunt C; Mitchell P; Sachdev PS; Trollor JN, (eds.), Createspace Independent Publishing Platform
,2013, Clinical management of bipolar disorder, Future Medicine Ltd, http://dx.doi.org/10.2217/9781780842585
,2013, Foreword: Clinical management of bipolar disorder, Future Medicine Ltd, http://dx.doi.org/10.2217/EBO.13.265
,, 2004, Mood Disorders Recognition and treatment, Joyce PR; Mitchell PB, (ed.), University of New South Wales Press, Sydney, Australia
Book Chapters
2024, 'Medications for Bipolar Disorder', in Tasman’s Psychiatry, Springer International Publishing, pp. 4181 - 4211, http://dx.doi.org/10.1007/978-3-030-51366-5_135
,2023, 'Medications for Bipolar Disorder', in Tasman’s Psychiatry, Springer International Publishing, pp. 1 - 31, http://dx.doi.org/10.1007/978-3-030-42825-9_135-1
,2021, 'The nature of depression in bipolar disorder', in The Nature of Depression, Elsevier, pp. 151 - 167, http://dx.doi.org/10.1016/b978-0-12-817676-4.00009-2
,2020, 'Therapeutic drug monitoring of antidepressant and antipsychotic drugs', in Handbook of Analytical Separations, pp. 257 - 275, http://dx.doi.org/10.1016/B978-0-444-64066-6.00011-3
,2020, 'Chapter 11 Therapeutic drug monitoring of antidepressant and antipsychotic drugs', in Methods of Therapeutic Drug Monitoring Including Pharmacogenetics, Elsevier, pp. 257 - 275, http://dx.doi.org/10.1016/b978-0-444-64066-6.00011-3
,2019, 'Antidepressants', in Side Effects of Drugs Annual, pp. 13 - 26, http://dx.doi.org/10.1016/bs.seda.2019.10.002
,2019, 'Management Commentary', in Bipolar II Disorder: Modelling, Measuring and Managing, pp. 246 - 249, http://dx.doi.org/10.1017/9781108333252.028
,2018, 'Antidepressants', in Side Effects of Drugs Annual, pp. 11 - 20, http://dx.doi.org/10.1016/bs.seda.2018.08.009
,2018, 'Chapter 9 Neuropsychological and social cognitive function in young people at genetic risk of bipolar disorder', in Bipolar Disorder Vulnerability, Elsevier, pp. 157 - 193, http://dx.doi.org/10.1016/b978-0-12-812347-8.00009-9
,2018, 'Neuropsychological and social cognitive function in young people at genetic risk of bipolar disorder', in Bipolar Disorder Vulnerability Perspectives from Pediatric and High-risk Populations, Academic Press
,2017, 'Suicide Bereavement in Adolescents', in Postvention in Action The International Handbook of Suicide Bereavement Support, pp. 27 - 38
,2017, 'Antidepressants', in Sidhartha R (ed.), Side Effects of Drugs Annual, Elsevier, pp. 9 - 21, http://dx.doi.org/10.1016/bs.seda.2017.06.010
,2017, 'Chapter 2 Antidepressants', in A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Elsevier, pp. 9 - 21, http://dx.doi.org/10.1016/bs.seda.2017.06.010
,2016, 'Antidepressant Drugs', in Side Effects of Drugs Annual, Elsevier, pp. 11 - 19, http://dx.doi.org/10.1016/bs.seda.2016.07.010
,2016, 'The history of bipolar disorder', in Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy, pp. 3 - 16, http://dx.doi.org/10.1007/978-3-319-31689-5_1
,2016, 'Chapter 2 Antidepressant Drugs', in A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Elsevier, pp. 11 - 19, http://dx.doi.org/10.1016/bs.seda.2016.07.010
,2015, 'Chapter 2 Antidepressants', in A worldwide yearly survey of new data in adverse drug reactions, Elsevier, pp. 15 - 31, http://dx.doi.org/10.1016/bs.seda.2015.06.013
,2014, 'Mood disorders', in Rieger E (ed.), Abnormal Psychology, McGraw Hill publication, Australia, pp. 89 - 132, http://www.mheducation.com.au/9781743078020-aus-abnormal-psychology-leading-researcher-perspectives
,2014, 'Biological therapies before the introduction of modern psychotropic drugs.', in López-Muñoz F; Álamo C; Domino EF (ed.), History of Psychopharmacology, NPP Books, Arlington, MA USA, pp. 327 - 347
,2014, 'Psychopharmacology', in Bloch S; Green SA; Holmes J (ed.), Psychiatry - past, present and prospect, Oxford University Press, UK, pp. 335 - 354, http://dx.doi.org/10.1093/med/9780199638963.003.0018
,2014, 'Chapter 2 Antidepressant Drugs', in A worldwide yearly survey of new data in adverse drug reactions, Elsevier, pp. 11 - 25, http://dx.doi.org/10.1016/b978-0-444-63407-8.00002-2
,2014, 'Chapter 2 Antidepressant drugs', in A worldwide yearly survey of new data in adverse drug reactions and interactions, Elsevier, pp. 27 - 39, http://dx.doi.org/10.1016/b978-0-444-62635-6.00002-4
,2013, 'Diagnosis and classification', in Clinical Management of Bipolar Disorder, Future Medicine Ltd, pp. 19 - 28, http://dx.doi.org/10.2217/EBO.13.255
,2013, 'Clinical management of bipolar disorder', in Clinical Management of Bipolar Disorder, Taylor & Francis, pp. 2 - 5, http://dx.doi.org/10.2217/ebo.13.265
,2013, 'Diagnosis and classification', in Clinical Management of Bipolar Disorder, Taylor & Francis, pp. 18 - 28, http://dx.doi.org/10.2217/ebo.13.255
,2012, '2 Antidepressant drugs', in A worldwide yearly survey of new data in adverse drug reactions and interactions, Elsevier, pp. 17 - 24, http://dx.doi.org/10.1016/b978-0-444-59499-0.00002-7
,2012, 'Antidepressant drugs', in Aronson JK (ed.), Side Effects of Drugs Annual, Elsvier, pp. 17 - 24
,2012, 'Psychiatrists and the Pharmaceutical Industry: on the ethics of a complex relationship', in Dudley M; Silove D; Gale F (ed.), Mental health and human rights: Vision, praxis, and courage, Oxford University Press, United Kingdom, pp. 346 - 361
,2011, 'Antidepressant drugs', in Aronson JK (ed.), Side Effects of Drugs Annual, Excerpta Medica, Amsterdam, pp. 25 - 38
,2011, 'Chapter 2 Antidepressant drugs', in A worldwide yearly survey of new data in adverse drug reactions, Elsevier, pp. 25 - 38, http://dx.doi.org/10.1016/b978-0-444-53741-6.00002-7
,2011, 'Course and outcome of bipolar disorder', in Manji HK; Zarate Jr CA (ed.), Behavioral Neurobiology of Bipolar Disorder and its Treatment, Springer, New York, pp. 1 - 18
,2011, 'Mood Disorders: an Australasian focus', in Rieger E (ed.), Abnormal Psychology: Leading Researcher Perspectives, McGraw Hill Publishers, Australia, pp. 91 - 132
,2011, 'Non-pharmacotherapeutic Somatic Treatments for Bipolar Disorder (ECT, DBS, rTMS)', in Manji HK; Zarate Jr CA (ed.), Behavioral Neurobiology of Bipolar Disorder and its Treatment, Springer, USA, pp. 285 - 302
,2008, 'Management commentary', in Bipolar II Disorder, Cambridge University Press (CUP), pp. 244 - 246, http://dx.doi.org/10.1017/cbo9780511544187.022
,2008, 'Impact of Mood, Anxiety, and Psychotic Symptoms on Cognition in Patients With Bipolar Disorder', in Goldberg JF; Burdick KE (ed.), COGNITIVE DYSFUNCTION IN BIPOLAR DISORDER: A GUIDE FOR CLINICIANS, AMER PSYCHIATRIC PRESS, INC, pp. 89 - 111, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294283700007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Impact of mood, and Psychotic Symptoms on cognition in Patients with Bipolar Disorder', in Goldberg JF; Burdick KE (ed.), Congitive Dysfunction in Bipolar Disorder A guide for Clinicans, American Psychiatric Publishing, Arlington, USA, pp. First - 89
,2008, 'Management Commentary', in Eyers G; Parker K (ed.), Bipolar 11 Disorder Modelling, Measuring and Managing, Cambridge University Press, Cambridge,UK, pp. 244 - 246
,2008, 'Mood disorders', in Rieger E (ed.), Abnormal Psychology: Leading Researcher Perspectives, McGraw-Hill, Australia, pp. 87 - 123
,2008, 'Mood Disorders', in Dowden J (ed.), Therapeutic Guidelines Psychotropic, Therapeutic Guidelines Ltd, Melb, Australia, pp. 101 - 131
,2007, 'Biological Therapies', in Bloch S; Singh BS (ed.), Foundations of Clinical Psychiatry (3nd Ed), Melbourne University Press, Australia, pp. 552 - 577
,2007, 'Cognitive Therapy Enchanced With Emotive Techniques in the Treatment of Bipolar Disorder', in Einstein DA (ed.), Innovations and Advances in Cognitive Behaviour Therapy, Australian Academic Press, Qld, Australia, pp. 145 - 156
,2007, 'Mindfulness Meditation and Bipolar Disorder', in Einstein DA (ed.), Innovations and Advances in Cognitive Behaviour Therapy, Australian Academic Press, Qld, Australia, pp. 37 - 42
,2006, 'A Medical Perspective', in Tort Liability for Psychiatric Damage, Law Book Company, Pyrmont, NSW, pp. 53 - 78
,2006, 'Biological therapies before the introduction of psychotropic drugs', in History of Psychopharmology, Panamericana, Madrid,Spain, pp. 901 - 926
,2004, 'Aetiology and Pathophysiology of Bipolar Disorder', in Joyce PR; Mitchell PB (ed.), Mood Disorders Recognition and treatment, University of New South Wales Press, Sydney, Australia, pp. 85 - 98
,2004, 'Mood disorders and the global burden of disease', in Joyce PR; Mitchell PB (ed.), Mood Disorders Recognition and treatment, University of New South Wales Press, Sydney, Australia, pp. 496 - 500
,